Purchase Order 75N91023P00806
Award Date 8/28/23
Potential Completion Date 9/27/23
Potential Value $20K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Encinitas, CA 92024, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $19,665.98 purchase order contract to Cell Culture Collective, Inc. for biological products. Under the firm fixed price contract, Cell Culture Collective will provide biologicals to support the NIH NCI's cancer research efforts. Performance will take place at Cell Culture Collective's facility in Encinitas, California over a period of one month concluding on October 7, 2023. No...
- <p>The National Cancer Institute issued a delivery order to Fisher Scientific Company L.L.C. on September 19, 2019, for fetal bovine serum (certified, United States Lot 2087367) with a ceiling value of $11,664.00.</p> <p>Place of performance is Pittsburgh, PA 15275. The order was priced on a firm fixed price basis and completed on September 28, 2019. This delivery order was issued under the GSA Multiple Award Schedule (Scientific Equipment and Services, FSS-66).</p>
- The National Cancer Institute awarded a $24.9K firm fixed-price contract to Research and Diagnostic Systems, Inc. (R&D Systems) on May 25, 2021, for the purchase of eighty-three 500 ml bottles of fetal bovine serum, Lot #K19150. This contract was executed as a call against an existing Blanket Purchase Agreement and represents a non-competitive procurement. The place of performance is Minneapolis, Minnesota, where R&D Systems maintains its headquarters as a subsidiary of Bio-Techne...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $14,399.52 firm fixed price purchase order to Bio-Techne Sales Corporation of Minneapolis, Minnesota. Under this contract, Bio-Techne will provide fetal bovine serum to support the NIH National Cancer Institute's research efforts. The one year contract runs from July 20, 2023 through July 19, 2024 and was awarded without any set aside designations. Bio-Techne will serve as the prime...
- The National Cancer Institute (NCI) awarded a Blanket Purchase Agreement (BPA) call valued at $11,745.00 to Sigma-Aldrich Corporation for the supply of fetal bovine serum of USA origin, sterile-filtered and hybridoma tested (Batch Number: 15A187). This contract was awarded on September 20, 2015, with an ultimate completion date of October 6, 2015, and utilized fixed-price pricing with economic price adjustment terms. The place of performance is designated as Bethesda, Maryland 20892, and no...
- The National Cancer Institute awarded a $14,976 firm fixed-price Blanket Purchase Agreement (BPA) call to Research and Diagnostic Systems, Inc. (R&D Systems) on August 18, 2021, for the supply of Fetal Bovine Serum – Optima, with performance completion by September 30, 2021. The award was made through open competition with no set-aside designation. R&D Systems, a Minneapolis-based manufacturer of biological research materials and subsidiary of Bio-Techne Corporation, specializes in...
- The National Cancer Institute awarded a $16,250 firm fixed price Blanket Purchase Agreement (BPA) call to Research and Diagnostic Systems, Inc. (R&D Systems) on May 5, 2021, for fetal bovine serum premium in 500 mL quantities. The contract, which was completed by May 27, 2021, was performed in Minneapolis, Minnesota, where R&D Systems is headquartered. No set-aside designation was used for this procurement, indicating open competition. R&D Systems, a subsidiary of Bio-Techne...
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Life Technologies Corporation for $13,121.80 on August 12, 2020, for the supply of fetal bovine serum. Place of performance is Grand Island, New York. The order was due for completion by November 10, 2020. Pricing is firm fixed price with no set-aside designation.</p>
- This firm fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, to Bio-Techne Sales Corporation, a for-profit organization specializing in biological research products and materials. The $12,757.50 contract is for the delivery of fetal bovine serum, a critical research material used in various medical and scientific research programs. The award has no...
- VWR International LLC, doing business as VWR International, has been awarded a purchase order contract valued at twenty-one thousand six hundred eighty dollars and eighty cents ($21,680.80) by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Under the terms of this firm fixed price contract, VWR International will provide Hyclone Fetal Bovine Serum of Canadian origin from Hyclone Products to...